148 related articles for article (PubMed ID: 10025821)
1. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
Sandson TA
Neurology; 1999 Feb; 52(3):675-6. PubMed ID: 10025821
[No Abstract] [Full Text] [Related]
2. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
Knopman DS
Neurology; 1998 May; 50(5):1203-5. PubMed ID: 9595961
[No Abstract] [Full Text] [Related]
3. Metrifonate: update on a new antidementia agent.
Ringman JM; Cummings JL
J Clin Psychiatry; 1999 Nov; 60(11):776-82. PubMed ID: 10584768
[TBL] [Abstract][Full Text] [Related]
4. New drug treatment for Alzheimer's disease. Treatment with metrifonate warrants multicentre trials.
Zamar AC; Wise ME; Watson JP
BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841012
[No Abstract] [Full Text] [Related]
5. Metrifonate for Alzheimer's disease patients.
Schneider LS
J Clin Psychiatry; 2000 Mar; 61(3):218-9. PubMed ID: 10817111
[No Abstract] [Full Text] [Related]
6. The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease.
Schmidt BH; Heinig R
Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():15-9. PubMed ID: 9718230
[TBL] [Abstract][Full Text] [Related]
7. [Alzheimer disease. Irreversible AChE inhibition with metrifonate].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1998 Aug; 21(8):250. PubMed ID: 9758555
[No Abstract] [Full Text] [Related]
8. Metrifonate: a new agent for the treatment of Alzheimer's disease.
Williams BR
Am J Health Syst Pharm; 1999 Mar; 56(5):427-32. PubMed ID: 10096702
[TBL] [Abstract][Full Text] [Related]
9. Evaluating response to metrifonate.
Tariot PN
J Clin Psychiatry; 1998; 59 Suppl 9():33-7. PubMed ID: 9720485
[TBL] [Abstract][Full Text] [Related]
10. Metrifonate. A viewpoint.
Taylor P
Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413708
[No Abstract] [Full Text] [Related]
11. Metrifonate for Alzheimer's disease.
López-Arrieta JM; Schneider L
Cochrane Database Syst Rev; 2006 Apr; (2):CD003155. PubMed ID: 16625573
[TBL] [Abstract][Full Text] [Related]
12. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.
Kaufer D
Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():8-14. PubMed ID: 9718229
[TBL] [Abstract][Full Text] [Related]
13. The clinical trial protocol of the Metrifonate in Alzheimer's Trial (MALT).
McKeith IG
Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():2-7. PubMed ID: 9718228
[TBL] [Abstract][Full Text] [Related]
14. Metrifonate: overview of safety and efficacy.
Cummings JL
Pharmacotherapy; 1998; 18(2 Pt 2):43-6; discussion 79-82. PubMed ID: 9543464
[TBL] [Abstract][Full Text] [Related]
15. Metrifonate. A viewpoint.
Giacobini E
Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413707
[No Abstract] [Full Text] [Related]
16. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B
Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967
[TBL] [Abstract][Full Text] [Related]
17. Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.
Cummings JL; Cyrus PA; Bieber F; Mas J; Orazem J; Gulanski B
Neurology; 1998 May; 50(5):1214-21. PubMed ID: 9595966
[TBL] [Abstract][Full Text] [Related]
18. Treating Alzheimer's disease with cholinergic drugs, Part 2.
Terpstra T; Terpstra T
Nurse Pract; 1999 Jan; 24(1):117-9. PubMed ID: 9950002
[No Abstract] [Full Text] [Related]
19. Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials.
Farlow MR; Cyrus PA
Dement Geriatr Cogn Disord; 2000; 11(4):202-11. PubMed ID: 10867446
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease.
Cummings JL; Nadel A; Masterman D; Cyrus PA
J Geriatr Psychiatry Neurol; 2001; 14(2):101-8. PubMed ID: 11419566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]